Summary of Report -
This research service presents an overview of the diabetes therapeutic market in India. It quantifies the market size and provides growth forecasts of the market from 2010 to 2016. It provides an in-depth analysis of key treatment challenges of diabetes management, market drivers and restraints, and how they affect the market dynamics during the forecast period. Insulin and oral anti-diabetic drugs are covered in detail, with market size and forecasting. Clinical trials in India for new classes of drugs for diabetes management are also covered.
Executive Summary
Research Objectives and Approach
Prevalence and Incidence of Diabetes in India
Treatment Challenges
Market Engineering Measurements
Market Assessment: Market Size, Market Drivers and Restraints
Market Assessment: Patient Share Forecast
Future Trends
Appendix
Decision Support Databases
About Frost & Sullivan
List of Figures
Diabetes Therapeutics Market: Snapshot of Diabetes Prevalence (India), 2010
Diabetes Therapeutics Market: Key Treatment Challenges (India), 2010
Diabetes Therapeutics Market: Market Drivers Ranked in Order of Impact (India), 2011-2016
Diabetes Therapeutics Market: Market Restraints Ranked in Order of Impact (India), 2011-2016
Diabetes Therapeutics Market: Key Multinational Participants with candidates in Phase 3-above (Asia-Pacific)
Diabetes Therapeutics Market: Key Domestic Participants (India), 2010
Diabetes Therapeutics Market: Clinical Trials Summary (Asia-Pacific)
Diabetes Therapeutics Market: Clinical Trials (India), 2010
Decision Support Database: New Cases of Diabetes (Global), 2002-2012
Decision Support Database: Diabetes Foot Ulcer Prevalence (Global), 2002-2012
Decision Support Database: Prevalence of Diabetes (Global), 2002-2012
Decision Support Database: Prevalence Percent of Diabetes (Global), 2002-2012
Overview of the Diabetes Therapeutics Market in India: Diabetes, an Apparent Epidemic in India: Opportunities for Pharmaceutical Companies, is available at:
http://www.reportbuyer.com/
